Anjo, very astute of you picking that point ..Also regarding Patents and other Stem cell companies Using our patens re “ when the time is right “ . I believe they can can carry out trials , obtain Approvals Talk to Pharmas , But before Commercialisation can take place Mesoblast can object or commence dialogue with the company regarding payments and royalties...Sounds like we may become busy in that environment... How bizarre is it when our patents must be worth around $3 of the Share price alone.. The company is only Cruising at this stage Can’t say the same for the next weeks and months thou...Cheers V
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-848
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.030(3.19%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 98.0¢ | 92.0¢ | $3.342M | 3.477M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33313 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 73982 | 2 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |